FDA Dietary Supplements (21 CFR 111)

US regulation

FDA dietary supplement cGMP requirements — manufacturing, packaging, labeling, holding operations.

Hard Rules

0

Ingredient-level regulatory restrictions

Linked Evidence

0

Mapped to known ingredients

Contextual Evidence

0

Not yet ingredient-mapped

Enforcement Events

0

Warnings, import alerts

Adverse Events

0

Post-market safety reports

Source Metadata

Slug

fda_dietary_supplements_21cfr111

Declared Record Count

0

No rules have been loaded from this source yet.

This page shows data as it exists in our database. Regulatory status can change; always verify with official sources before making compliance decisions. This tool is for informational purposes only and does not constitute legal or regulatory advice.

Legal Disclaimer

This service is provided "AS IS" without warranties of any kind. Regulatory data is for reference only and does not constitute legal or regulatory advice. Always consult a qualified attorney or regulatory consultant before making compliance decisions. Not affiliated with the U.S. Food and Drug Administration (FDA) or any government agency. IngredientCompliance is an independent tool operated by Gerim-Sterling LLC. © 2026 Gerim-Sterling LLC.

Dispute Resolution — Binding Arbitration: By using this service, you agree that any dispute, claim, or controversy arising out of or relating to these terms or the use of this service shall be resolved exclusively through final and binding individual arbitration administered by the American Arbitration Association (AAA) under its Consumer Arbitration Rules, and not in any court. You waive any right to participate in a class action lawsuit or class-wide arbitration. Arbitration shall be conducted remotely via video conference under AAA's Consumer Arbitration Rules, with no required physical appearance. This clause does not prevent either party from seeking emergency injunctive relief in a court of competent jurisdiction where necessary to prevent irreparable harm.